Why China internet users rare email usage, as it does in the rest of the world: Since the world's first e-mail was sent in 1971, this form of communication has experienced great growth.
Today, more than 2.630 million emails are sent and received every day-more or less the ones you have in your inbox when you come back from vacation-it is common to have a private email address and a work address at least, and you can't think of a day where you don't have to face the hassle of checking and answering pending emails. .
Believe it or not, China has largely managed to get rid of that task and its citizens barely use e-mail.
It's not that instant messaging apps and mobile phones have finished with email in China today, it's that this format never even got off the ground among its citizens, who have always opted in general for chats and apps to communicate with family, friends and even in the workplace.
This lower dependence on mail in China is linked to the development of the internet and computers in the country.
As an elaborate article on the subject in Quatz notes, in the late 1990s, when the use of the network was beginning to be standardized, computers were already a relatively frequent element of households in the US and other parts of the West. While in China they were far from it.
According to the World Bank, in 1999 there were 50.5 computers per 100 people in the US while in China this figure was reduced to 1.2. As for Spain, the volume reached 12.02.
China internet users rare email usage
Thus, in the West, e-mail began to emerge more and more as a popular form of communication between offices, universities, etc.as computers entered more spheres of everyday life.
In China, on the other hand, internet contact for much of society came from the hands of internet cafes that began to emerge in the early 2000s. There, customers mostly opted for chat, a much more immediate form of contact than the email.
Just then, the Chinese company Tencent had just created the QQ computer messaging application, which became the favorite of users of these internet cafes. Launched in 1999, in 2015 it had 829 million active accounts and even today it is positioned as one of the most popular websites in the country.
In this way, China was launching itself into the immediacy of communication on the net, before mobile and social networks enhanced its use around the world.
The failure of e-mail has also come driven by China's own corporate culture.
This Is What Zhong Ling, an assistant professor of Economics at the Cheung Kong School of business in Beijing, considers. According to an article for BBC, "the culture and business environment in China motivate a demand to respond immediately," which hardly matches the almost letter style imposed by emails.
"Employers and managers often send requests or assignments outside normal working hours and prefer not to wait until the next business day for a trivial response," he tells the media.
Similarly, Alan Casey of Prophet consulting, with offices throughout Asia, thinks. As he tells the BBC, his team has seen how in front of the mail applications have much greater presence in this part of the world.
"Many countries like China and Southeast Asia have skipped the era of computers and moved directly to that of mobile connectivity," he says.
This is where WeChat, the instant messaging app also created by Tencet in 2011, comes in, which today ranks as one of the most used in China for almost everything.
This app allows a variety of actions, which goes even beyond imaginable. Not only send messages to contacts, but also book appointments, pay for purchases and even end your marriage. It also has the WeChat work version, focused on companies, from which it is also possible to manage documents, payroll or employee assistance. So from the same application Chinese citizens can control all the services they need.
"[In the Uk] you Can buy some products on Amazon, food in some applications, and make reservations and quotations in websites, but all of them require e-mail or an account on Facebook; it is not like in China, where you use your account WeChat for all", sums up the BBC, Hailan Jia, head of public relations at a chinese company in United Kingdom.
End of the China internet users rare email usage article
Vaccine manufacturers have not yet included children in their clinical trials, showing that they are not the priority and that they will take longer to receive a possible injection
The progress of coronavirus vaccines has been very rapid since the new virus was first identified and sequenced in January. The main experimental vaccines are now in the final phase of clinical trials, and results are expected to arrive next month.
But that progress has focused on the development and testing of an adult vaccine. Children have not yet participated in any coronavirus vaccine trials, prompting some experts to worry that children will be left without a viable vaccine against COVID - 19 for some time.
Pharmacists often test a vaccine on children before seeking approval to give injections to children.
Business Insider has consulted leading drug manufacturers-Pfizer, Moderna, AstraZeneca, and Johnson & Johnson-for their plans to test their coronavirus vaccines on children. All four companies assure us that they plan to do so, but none provide an estimated time frame for when a vaccine might be available for children.
At this time, the four companies are in the final stage of testing their experimental vaccines on adults.
Moderna explains to Business Insider that he plans to begin a pediatric test for his vaccine before the end of the year, depending on the approval of regulators.
"Subject to regulatory approval, our intention is to start later this year," says Ray Jordan, director of Corporate Affairs at Moderna.
Jordan adds that Moderna has nothing more to share publicly about the timing, protocols or funding of pediatric studies " because these regulatory discussions are still underway."
Johnson & Johnson's scientific director, Paul Stoffels, states that J&J is committed to eventually conducting pediatric trials. The opening of studios for children "will come later in the year" after safety is established in adults, Stoffels said in a conversation with journalists on September 22.
The other pharmaceutical companies do not share when they would begin their studies in children.
The lack of information on how and when manufacturers plan to test their coronavirus vaccines in children has caused concern among some pediatricians and vaccine experts.
"Right now I'm pretty concerned that we won't have a vaccine available to children by the beginning of next school year," Dr. Evan Anderson, a pediatrician at Children's Healthcare in Atlanta, tells Carl Zimmer of the New York Times.
Business Insider has asked leading drug manufacturers whether they expect to receive government funding to conduct these trials. None responded directly to the question, although an AstraZeneca spokesman notes that its agreement with the U.S. government includes pediatric studies.
The U.S. government's initiative to accelerate the development of coronavirus vaccines has committed approximately $ 10 billion (about € 8.57 billion) to pharmaceutical companies to fund trials, produce doses and purchase in advance a supply of several experimental vaccines. The leaders of Operation Warp Speed have not presented, or even mentioned, a plan to vaccinate children in recent months.
A couple of factors explain why children are falling behind in this investigation.
In general, researchers begin to test an experimental vaccine in the less vulnerable population — young, healthy adults - and then begin to expand to more vulnerable groups as clinical data builds up that shows the vaccine is worth testing. This may include testing on older people and people with other diseases.
A recent change in the Pfizer coronavirus vaccine study shows how it works. The pharmaceutical giant recently increased its enrollment target from 30,000 volunteers to 44,000 people, and it also said it now wants to enroll young people aged 16 and 17, as well as people with hepatitis C, Hepatitis B and HIV.
"To address the burden of disease in pediatric populations under the age of 16, we are actively working with regulators on a possible pediatric study plan," notes a Pfizer spokesman.
Although children do not often suffer from the severe results of COVID-19 seen in the elderly, finding a vaccine for children remains an important element in countering this pandemic.
"Although children infected with SARS-CoV-2 are more likely to be asymptomatic, a symptomatic and sometimes severe disease occurs," explains Pfizer's spokesman. "In addition, children can be important in the spread of SARS-CoV - 2 to the community."